Forbion Continues Funding Efforts, Raises $208M for More Investments

Forbion, a European life sciences venture capital firm, announced today that it had closed its Forbion Growth Opportunities Fund at $208 million. Existing investors including Pantheon, KfW Capital and the European Investment Fund contributed to the financing, which will go toward late-stage investments.